PCN221 Treatment Patterns Including Adherence/Persistence with Cyclin-Dependent Kinase 4&6 Inhibitors (CDK4&6I) Among US Commercially Insured Women with Metastatic Breast Cancer (MBC)
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI